Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09BOH
|
||||
Former ID |
DIB006454
|
||||
Drug Name |
Verubulin
|
||||
Synonyms |
Azixa; Verubulin hydrochloride; EP-128495; MPC-6827; Apoptosis inducer (cancer), Myriad; Caspase inducer (cancer), Myriad; Cell cycle arrest inducer (cancer), Myriad; Tubulin inhibitor (cancer), Myriad
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [523339] | ||
Company |
Maxim Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H17N3O
|
||||
Canonical SMILES |
N(c1nc(nc2c1cccc2)C)(C)c1ccc(cc1)OC
|
||||
CAS Number |
CAS 827031-83-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | ||
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.